Search research articles
Contact Us
Filters
Showing results (251-260 of 369) with videos related to
Page
of 37
Sort By:
Journal of Gastrointestinal Cancer
|
May 22, 2015
Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis
F Petrelli, E Pezzica, M Cabiddu, et al.
Oncology Reports
|
May 21, 2011
A randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patients
P Lissoni, A Ardizzoia, S Barni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 16, 2000
Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status
P Lissoni, S Barni, M Mandalà, et al.
Tumori
|
July 1, 1995
Clinical efficacy of cancer subcutaneous immunotherapy with interleukin-2 in relation to the pretreatment levels of tumor growth factor insulin-like growth factor-1
P Lissoni, S Barni, A Ardizzoia, et al.
Annals of the New York Academy of Sciences
|
August 15, 1998
Histiocytic activation following neutron irradiation of boron-enriched rat liver metastases
R Nano, S Barni, G Gerzeli, et al.
European Journal of Histochemistry : EJH
|
January 31, 2013
Dipeptidylpeptidase--IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats
E Tarantola, V Bertone, G Milanesi, et al.
Advances in Space Research : the Official Journal of the Committee on Space Research (COSPAR)
|
January 1, 1992
Lymphocytes on sounding rockets
M Cogoli, B Bechler, A Cogoli, et al.
Anticancer Research
|
May 1, 1990
Histochemical probes for the detection of hypoxic tumour cells
I Freitas, P Pontiggia, S Barni, et al.
Oncology Reports
|
May 21, 2011
Efficacy and tolerability of cancer neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin - a progress report of 200 patients with advanced solid neoplasms
P Lissoni, A Ardizzoia, S Barni, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
June 1, 1997
[Immunotherapy for metastatic renal carcinoma with interleukin-2 in a subcutanous administration schedule of short duration. Subcutaneous IL-2 in renal carcinoma]
P Lissoni, S Barni, A Ardizzoia, et al.
Page
of 37
Search research articles
Search
Showing results (251-260 of 369) with videos related to
Sort By:
Page
of 37
Journal of Gastrointestinal Cancer
|
May 22, 2015
Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis
F Petrelli, E Pezzica, M Cabiddu, et al.
Oncology Reports
|
May 21, 2011
A randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patients
P Lissoni, A Ardizzoia, S Barni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 16, 2000
Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status
P Lissoni, S Barni, M Mandalà, et al.
Tumori
|
July 1, 1995
Clinical efficacy of cancer subcutaneous immunotherapy with interleukin-2 in relation to the pretreatment levels of tumor growth factor insulin-like growth factor-1
P Lissoni, S Barni, A Ardizzoia, et al.
Annals of the New York Academy of Sciences
|
August 15, 1998
Histiocytic activation following neutron irradiation of boron-enriched rat liver metastases
R Nano, S Barni, G Gerzeli, et al.
European Journal of Histochemistry : EJH
|
January 31, 2013
Dipeptidylpeptidase--IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats
E Tarantola, V Bertone, G Milanesi, et al.
Advances in Space Research : the Official Journal of the Committee on Space Research (COSPAR)
|
January 1, 1992
Lymphocytes on sounding rockets
M Cogoli, B Bechler, A Cogoli, et al.
Anticancer Research
|
May 1, 1990
Histochemical probes for the detection of hypoxic tumour cells
I Freitas, P Pontiggia, S Barni, et al.
Oncology Reports
|
May 21, 2011
Efficacy and tolerability of cancer neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin - a progress report of 200 patients with advanced solid neoplasms
P Lissoni, A Ardizzoia, S Barni, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
June 1, 1997
[Immunotherapy for metastatic renal carcinoma with interleukin-2 in a subcutanous administration schedule of short duration. Subcutaneous IL-2 in renal carcinoma]
P Lissoni, S Barni, A Ardizzoia, et al.
Page
of 37